Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.
暂无分享,去创建一个
G. M. Allan | Brian W. Hudson | K. Zarnke | M. Kolber | J. McCormack | R. Padwal | Ann Comeau | Scott R. Garrison | S. Garrison | Marco Mannarino | Adrienne J Lindblad | Sharon Nickel | Candra Cotton | C. Korownyk | J. Coppola | Cindy McMinis | Christine Schelstraete
[1] T. Ivanova,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice , 2016 .
[2] David R Thompson,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.
[3] G. M. Allan,et al. Comparison of cardiovascular disease risk calculators , 2014, Current opinion in lipidology.
[4] T. Wadden,et al. Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.
[5] Janusz Wnek,et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[6] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[7] G. M. Allan,et al. Treating to target: ready, fire, aim. , 2014, Canadian family physician Medecin de famille canadien.
[8] G. M. Allan,et al. Statin-induced diabetes: too sweet a deal? , 2013, Canadian family physician Medecin de famille canadien.
[9] G. M. Allan,et al. Agreement Among Cardiovascular Disease Risk Calculators , 2013, Circulation.
[10] Simon L Bacon,et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. , 2013, The Canadian journal of cardiology.
[11] Mikael Fogelholm,et al. Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013 .
[12] Robert Dufour,et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. , 2013, The Canadian journal of cardiology.
[13] M. Taljaard,et al. Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study , 2012, BMC Cardiovascular Disorders.
[14] R. Collins,et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. , 2012, Lancet.
[15] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[16] Lawrence A Leiter,et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative , 2011, Canadian Medical Association Journal.
[17] Salomeh Keyhani,et al. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study , 2011, BMJ : British Medical Journal.
[18] P. Kolh,et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.
[19] F. Rodríguez-Salvanés,et al. Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS Study. , 2011, Revista espanola de cardiologia.
[20] D. Lee,et al. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. , 2011, Archives of internal medicine.
[21] D. Mikhailidis,et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis , 2010, The Lancet.
[22] R. Califf,et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. , 2009, JAMA.
[23] R. Jackson,et al. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? , 2008, Heart.
[24] F. McAlister,et al. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials , 2008, Canadian Medical Association Journal.
[25] S. Mohiuddin,et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. , 2007, Chest.
[26] Alicja R Rudnicka,et al. Statin safety: a systematic review. , 2006, The American journal of cardiology.
[27] Katrina M. Krause,et al. Is There Time for Management of Patients With Chronic Diseases in Primary Care? , 2005, The Annals of Family Medicine.
[28] N. Anthonisen,et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial , 2005 .
[29] T. Wilt,et al. Effectiveness of statin therapy in adults with coronary heart disease. , 2004, Archives of internal medicine.
[30] G. Schuler,et al. Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial , 2004, Circulation.
[31] Katrina M. Krause,et al. Primary care: is there enough time for prevention? , 2003, American journal of public health.
[32] D. Pella,et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial , 2002, The Lancet.
[33] P. Touboul,et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.
[34] G. M. Allan,et al. Contributors to primary care guidelines: What are their professions and how many of them have conflicts of interest? , 2015, Canadian family physician Medecin de famille canadien.
[35] Lawrence A Leiter,et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. , 2013, The Canadian journal of cardiology.
[36] S. Greenfield,et al. Clinical practice guidelines we can trust , 2011 .